Title: Iran’s Pharmaceutical Association Proposes Framework for Medication Consultation Fees
Tehran – In a significant development for Iran’s healthcare sector, the head of the Iranian Pharmacists Association has formally submitted a proposal to the country’s Food and Drug Administration regarding the establishment of tariffs for pharmaceutical consultation services.
A Formal Proposal for Structured Fees
The proposal was detailed in a letter from Dr. Shahram Kalantari Khandani, the President of the Iranian Pharmacists Association, addressed to Dr. Mehdi Pir-Salehi, the head of the Food and Drug Organization. The communication outlines a structured approach to determining appropriate fees for the professional consultation services provided by pharmacists to the public within pharmacies.
Focus on Professional Services
The initiative highlights the ongoing efforts within the Islamic Republic of Iran to systematize and professionalize its healthcare services. The proposed framework aims to formally recognize the critical role pharmacists play in offering expert advice on medication use, which contributes directly to enhanced public health and patient safety.
This move is seen as a step towards further integrating and valuing the expertise of pharmaceutical professionals within the nation’s robust healthcare system. The proposal is now under formal review by the relevant regulatory body.